Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tamura A"'
Autor:
Hiroko, Tsukada, Akira, Yokoyama, Koichi, Goto, Tetsu, Shinkai, Masao, Harada, Masahiko, Ando, Taro, Shibata, Yuichiro, Ohe, Tomohide, Tamura, Nagahiro, Saijo, S, Yokota
Publikováno v:
Japanese Journal of Clinical Oncology. 45:88-95
OBJECTIVE Prospective trials specifically designed for elderly patients with advanced non-small-cell lung cancer demonstrating the benefit of platinum-based therapies are still lacking. This trial was designed to clarify whether the addition of cispl
Autor:
Tomohide Tamura, Noboru Yamamoto, Shintaro Kanda, Yutaka Fujiwara, Satoru Kitazono, Ayako Tanaka, Koji Tsuta, Shigehiro Yagishita, Hidenori Mizugaki, Hiroshi Nokihara, Hisao Asamura, Hidehito Horinouchi
Publikováno v:
Japanese Journal of Clinical Oncology. 44:835-840
OBJECTIVE Several clinical studies have demonstrated the efficacy and safety of adjuvant chemotherapy in patients with completely resected small cell lung cancer for a selected limited stage. However, it is unclear whether adjuvant chemotherapy is fe
Autor:
Nobuyuki Yamamoto, Takeshi Horai, Makoto Nishio, Stefanie Senger, Kazuhiko Nakagawa, Ikuo Sekine, Fumiyoshi Ohyanagi, Tomohide Tamura, Nassim Morsli
Publikováno v:
Japanese Journal of Clinical Oncology. 41:718-722
Preliminary safety findings are presented from the open-label Phase I part of a combined Phase I/II study of BLP25 liposome vaccine (L-BLP25) in Japanese patients with unresectable Stage III non-small-cell lung cancer after primary chemoradiotherapy.
Autor:
Nagahiro Saijo, Hideo Kunitoh, Kiyoshi Mori, Koshiro Watanabe, Tomoki Fujii, Hiroaki Okamoto, Haruhiko Fukuda, Tomohide Tamura, Akira Yokoyama, Hiroshi Kunikane
Publikováno v:
Japanese Journal of Clinical Oncology. 39:784-790
Objective It is important to find optimal regimens of cisplatin (CDDP)-based third-generation chemotherapy and radiotherapy for patients with unresectable Stage III non-small cell lung cancer (NSCLC). Methods This Phase II study was designed to deter
Autor:
Chikako Shimizu, Masashi Ando, Norikazu Masuda, Kenichi Yoshimura, Masayuki Mano, Yasuhiro Fujiwara, Hitoshi Tsuda, Kenji Tamura
Publikováno v:
Japanese Journal of Clinical Oncology. 39:484-490
Objective: Determinants of long-term outcome of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer who received neoadjuvant chemotherapy (NAC) are not clear. The purpose of this study was to explore the prognostic fa
Autor:
Ryuya Yamanaka, Tetsuro Tamura, Naoto Tsuchiya, Junpei Homma, Naoki Yajima, Hiroaki Hondoh, Masakazu Sano, Ryuichi Tanaka, Ken Morii, Yoshikatsu Shinbo, Hitoshi Takahashi, Tatsuyuki Kakuma
Publikováno v:
Japanese Journal of Clinical Oncology. 38:373-380
Background: Chemotherapy with or without radiotherapy is the mainstay of treatment for primary central nervous system lymphoma (PCNSL). High-dose methotrexate (MTX) is the most effective drug available to treat these lesions, either as a single agent
Autor:
Shun-ichi Watanabe, Hirotsugu Kenmotsu, Noboru Yamamoto, Tomohide Tamura, Hisao Asamura, Seiji Niho, Masahiro Tsuboi, Hiroshi Katayama, Junko Eba, Taro Shibata
Publikováno v:
Japanese journal of clinical oncology. 44(4)
A randomized Phase III trial commenced in Japan in March 2013. Post-operative adjuvant chemotherapy with etoposide plus cisplatin is the current standard treatment for resected pulmonary high-grade neuroendocrine carcinoma including small cell lung c
Autor:
Kenji Tamura
Publikováno v:
Japanese Journal of Clinical Oncology. :hyv131
Cellular proliferation is tightly controlled by several cell-cycle checkpoint proteins. In cancer, the genes encoding these proteins are often disrupted and cause unrestrained cancer growth. The proteins are over-expressed in many malignancies; thus,
Autor:
Tomohide Tamura, Hiroshi Nokihara, Hideo Kunitoh, Yuichiro Ohe, Yoshinori Ito, Noboru Yamamoto, Ikuo Sekine, Chiharu Tanai, Minako Sumi
Publikováno v:
Japanese journal of clinical oncology. 39(11)
Objective: To identify any gender differences in the outcomes of concurrent platinum-based chemotherapy and thoracic radiotherapy for unresectable stage III non-small cell lung cancer (NSCLC). Methods: A comparative retrospective review of the clinic
Autor:
Yoko Karube, Hideo Umezu, Nobuhide Masawa, Motohiko Tamura, Osamu Araki, Koichi Honma, Norio Seki, Hiromi Ishihama, Shinichiro Miyoshi, Masayuki Chida
Publikováno v:
Japanese journal of clinical oncology. 39(1)
BACKGROUND A recent meta-analysis study showed that post-operative adjuvant chemotherapy with UFT, an oral combination drug composed of tegafur [prodrug of 5-fluorouracil (5-FU)] and uracil [inhibitor of dihydropyrimidine dehydrogenase (DPD)] was ass